SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-098875
Filing Date
2022-04-07
Accepted
2022-04-07 16:09:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d343107d424b5.htm 424B5 3117
2 GRAPHIC g343107g0407073753004.jpg GRAPHIC 6569
  Complete submission text file 0001193125-22-098875.txt   13259
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-253539 | Film No.: 22813957
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences